A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (sti 571, glivec®)
Open Access
- 3 March 2003
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 120 (5) , 911-913
- https://doi.org/10.1046/j.1365-2141.2003.04151_4.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Stevens–Johnson syndrome after treatment with STI571: a case reportBritish Journal of Haematology, 2002
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002
- Cutaneous Reactions to STI571New England Journal of Medicine, 2001
- Lichenoid chronic graft-versus-host disease–like acrodermatitis induced by hydroxyureaJournal of the American Academy of Dermatology, 2001
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001